HTFS-III will show you how high throughput technology is helping to provide companies with faster, cheaper and high quality formulations, as well as providing insight into how you should implement and improve your HTFS.
The Formulation Science and Technology group (FSTG) of the Royal Society of Chemistry is pleased to announce that the third HTFS conference will be hosted by the National Formulation Centre at Sedgefield.
This will be held on Wednesday 26th April 2017 at the National Formulation Centre, CPI, Sedgefield.
High Throughput Formulation Screening III - From discovery to manufacture
When HTFS-I and HTFS-II were held, in 2006 and 2008, the use of high throughput technologies in formulation was still in its infancy and terms such as big data had not yet been coined. In 2017 high throughput techniques are now a key part of a formulators toolbox, combined with both the classical statistical tools, such as design of experiments, but also with new data mining techniques from the world of big data. During HTFS-III practioneers with decades of high throughput experience among them will share key learning from the routine use of high throughput techniques to accelerate and de-risk formulation at all stages from discovery to manufacture. HTFS-III will also give you an insight into the future developments that are changing formulation from a largely empirical science to hybrid of science and engineering which will see new formulations based on designs predicted through simulations, high throughput measurements and big data mining of existing product performance data.
The meeting is being held at the National Formulation Centre to allow the HTFS-III delegates to be some of the first to see the £3 million investment that has been made in an open access high throughput laboratory at Sedgefield, which is a key component of the national formulation strategy.
Speakers (see programme page for titles):
- Dr John Carroll, National Formulation Centre, UK
- Professor Peter Fryer, Birmingham University, UK
- Dr James Cawse, Cawse and Effect, Massachusets, USA
- Chris Lampard, AkzoNobel, UK
- Dr Mark Baker, Unilever, UK
- Jamie Marsay, Labman Automation, UK
- Dr Ian Tovey, Syngenta, UK
Dr Stephen Bysouth, Automaxion, France
Dr John Carroll, National Formulation Centre, CPI, UK
Dr Simon Gibbon, AkzoNobel RD&I, UK
Dr Helen Ryder, The University of Manchester, UK